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Alzheimer’s disease is the most prevalent neuro-
degenerative disease, characterized clinically by progression of
memory loss and pathologically by the presence of senile
plaques, neurofibrillary tangles, and extensive neuronal loss (1).
The major constituent protein (b /A4) of amyloid plaques, which
are a hallmark of this disease, is proteolytically derived from the
b /A4 amyloid precursor protein (APP).  Encoded by a single
gene on chromosome 21, APP belongs to a family of
alternatively spliced Type I integral transmembrane glyco-
proteins (Figure 1), the cellular function of which is unknown.
After the identification of APP695 (2), which consists of 695
residues, at least 10 isoforms of APP have been identified,
resulting from alternative splicing of a single gene.  Neurons
express high amounts of APP695, while longer APPs (751 and
770), containing a Kunitz-type protease inhibitor (KPI) insert,
and those lacking exon 15 (L-APPs) are more abundant in peri-
pheral tissues (1).  Genetic studies have revealed that point
mutations cosegregate with the disease phenotypes (1).
Therefore, structural alterations of APP are thought to be one
etiology of the disease, although their molecular mechanisms
remain unclear.
As shown in Figure 1, APP structurally resembles a type of
cell-surface receptors consisting of a glycosylated extracellular
domain with a cysteine-rich region, a single transmembrane
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Amyloid precursor protein (APP) is one of the major causative agents of Alzheimer’s disease and possesses a
receptor-like structure with extracellular, single transmembrane, and cytoplasmic domains.  To explore the
physiological significance of APP in the cell, we focuses on the possible involvement of APP in signal transduction
pathways.  Using affinity precipitation followed by an in vitro kinase assay, we found an APP-associated protein
kinase activity in the cytosol/membrane fraction of human cell lines derived from neuroblastoma, glioblastoma,
embryo, epidermis, and cervix cancer.  The kinase was capable of phosphorylating APP- and/or kinase-associated
cellular proteins and of binding to a part of the extracellular domain of APP.  The kinase activity was specific for
serine residues.  These results suggest that APP may function in a form of heteromer with a membrane-spanning
receptor-like kinase via binding to the extracellular domain characteristic of other receptor systems.
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Scope  of  Research
This laboratory was founded in 1994 with the aim of linking biomedical research and clinical medicine.  Thus, the
scope of our research encompasses the structure/function/regulation of various biomolecules, the pathophysiological
significance of divergent bioreactions, the specific abnormalities that cause diseases, and the application of molecular
techniques to clinical diagnosis and therapy.  Our current interest is focussed on poly(ADP-ribosyl)ation of cellular
proteins in relation to carcinogenesis, phosphorylation and NuLS-dependent nuclear localization of proteins related to
apoptosis and leukemogenesis, the pathophysiological role of Alzheimer b /A4 amyloid precursor protein (APP) and its
associated kinase in signal transduction pathways, the aberrant splicing of the APP gene transcript, and the etiological
linkage of Alzheimer’s disease to the apolipoprotein e 4 allele. 
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domain, and a cytoplasmic domain (2). Actually, APP is
localized in the cell membrane as an N- and O-glycosylated form
(3). Immunohistochemical studies revealed a patchy and
punctate appearance of APP on neurons in rat brain.  It has been
pointed out that the cytoplasmic domain of APP contains the
tetrapeptide sequence, NPTY, which conforms to the consensus
sequence, NPXY, required for the rapid endocytosis of the LDL
receptor. Subsequently, it has been shown that APP expressed
on the cell surface is internalized and delivered to the
prelysosomal/lylsosomal branch of the endocytic pathway (3).
Ser730 and Thr729 in the cytoplasmic domain are phosphorylatable
by protein kinase C and Ca2+/calmodulin-dependent kinase II (1).
This phosphorylation might be involved in the regulation of
unknown APP function(s) and/or the transduction of unknown
signaling(s).
In order to explore the pathophysiological significance of
APP, we focuses on the possible involvement of APP in signal
transduction pathway.  Based on computer analysis of the
predicted secondary structures, surface probability, antigen
index, flexibility, and hydrophobicity, we synthesized a series of
APP peptides for affinity precipitation (Figure 1).  By using the
affinity precipitation method followed by in vitro kinase assay,
we discovered an APP-associated kinase activity in the
cytosol/membrane fraction from a variety of human cell lines.
Figure 2 shows typical data with neuroblastoma cells, BIM, and
glioblastoma cells, T98G (4).  The APP95-115 sequence in the
extracellular domain of APP is a binding site for the kinase or
kinase-associated proteins.  The APP-associated kinase is
capable of phosphorylating APP- and/or kinase-associated
protein(s) at serine residues but not tyrosine residues. The kinase
requires Mn2+ and Mg2+ for activation.  APP-associated kinase is
distributed on the cell membrane (Figure 3).  Taken together, we
suggest that APP may function in a form of heteromer with a
membrane-spanning receptor-like protein with a kinase activity
via binding to the extracellular domain as known for other
receptor signaling systems.      
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Figure 1. Molecular structure of Alzheimer b /A4 amyloid precursor
proteins (APPs).  Three major isoforms of APP, APP770, APP751
and APP695, have been identified as a result of alternative splicing of
a single gene. The oligopeptides indicated were chemically
synthesized using t-butoxycarbonyl amino acids and p-
methylbenzhydrylamine resins, coupled to EAH-Sepharose 4B
support by 1-ethyl-3-(3-dimethylaminopropyl)carbodiimido
hydrochloride, and used for affinity precipitation followed by in vitro
kinase assay (5,6).
Figure 2. Detection of APP-associated protein kinase activity in
human cell lines derived from neuroblastoma (BIM) and
glioblastoma (T98G).  A, APP peptide-Sepharose beads were
incubated with cytosol/membrane fractions from BIM and T98G (6).
Recovered affinity complexes on the beads were resuspended in the
kinase reaction mixture containing [ g -32P]ATP and exogeneous
substrate, enolase, for 10 min at 25°C. After gel electrophoresis, the
APP-associated kinase activities were detected by autoradiography.
B, phosphoamino acids of proteins phosphorylated by APP-
associated kinase were separated by high-voltage electrophoresis and
identified by autoradiography (7). 
Figure 3. Subcellular localization of APP-associated kinase(s).
T98G cells were incubated with fluorescein isothiocyanate-labeled
APP95-115 peptide (5). Subcellular localization of the bound peptide
(APP-associated kinase) was visualized by fluorescence microscopy
(F). The cells were also viewed by phase-contrast microscopy (P).
